| Literature DB >> 35736097 |
Meng-Qiu Yan1, Xiao-Wei Su1, Yan-Fang Liu1, Chuan-Hong Tang1, Qing-Jiu Tang1, Shuai Zhou1, Yi Tan1, Li-Ping Liu1, Jing-Song Zhang1, Jie Feng1.
Abstract
The effects of oleic acid addition methods on the metabolic flux distribution of ganoderic acids R, S and T's biosynthesis from Ganoderma lucidum were investigated. The results showed that adding filter-sterilized oleic acid in the process of submerged fermentation and static culture is of benefit to the synthesis of ganoderic acids R, S and T. The metabolic fluxes were increased by 97.48%, 78.42% and 43.39%, respectively. The content of ganoderic acids R, S and T were 3.11 times, 5.19 times and 1.44 times higher, respectively, than they were in the control group, which was without additional oleic acid. Ganoderic acids R, S and T's synthesis pathways (GAP), tricarboxylic acid cycles (TCA), pentose phosphate pathways (PP) and glycolysis pathways (EMP) were all enhanced in the process. Therefore, additional oleic acid can strengthen the overall metabolic flux distribution of G. lucidum in a submerged fermentation-static culture and it can reduce the accumulation of the by-product mycosterol. This study has laid an important foundation for improving the production of triterpenes in the submerged fermentation of G. lucidum.Entities:
Keywords: Ganoderma lucidum; ganoderic acid; metabolic flux analysis; oleic acid; submerged fermentation-static culture
Year: 2022 PMID: 35736097 PMCID: PMC9225475 DOI: 10.3390/jof8060615
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1Substrate and product contents of G. lucidum submerged fermentation-static culture under different oleic acid addition methods.
Figure 2The metabolic network of ganoderic acids R, S and T synthesis by G. lucidum, submerged fermentation-static culture. AcAcCoA—acetoacetyl coenzyme A; AcCoA—Acetyl Coenzyme A; DMAPP—Dimethylallyl pyrophosphate; E4P—Erythrose-4-phosphate; ERG—Ergosterol; ERG (e)—Extracellular ergosterol; F6P—fructose-7-phosphate; FADH2—Reduced Flavin Dinucleotide; FPP—Farnesylpyrophosphate; G6P—Glucose-6-phosphate; GA3P—glyceraldehyde 3-phosphate; Ga R, S, T—Ganoderic acid R, Ganoderic acid S, Ganoderic acid T; GGPP—geranylgeranyl pyrophosphate; GLC—Glucose; GLC (e)—Extracellular glucose; GPP—Geranyl pyrophosphate; ICI—Isocitric acid; IPP—Isopentenyl pyrophosphate; LAN—Lanosterol; MY—Mycosterol; NADH—Nicotinamide adenine dinucleotide; OAA—Oxaloacetic acid; OS—2,3-Oxidosqualene; PYR—Pyruvate; PYR (e)—Extracellular pyruvate; R5P—Ribose-5-phosphate; Ru5P—ribulose 5-phosphate; SQ—Squalene; X5P—Xylulose phosphate; α-KG—α-ketoglutaric acid; α-KG (e)—Extracellular α-ketoglutaric acid.
Metabolic reaction equations and metabolic node reaction rate equations of ganoderic acids R, S and T’s synthesis from submerged fermentation-static culture of G. lucidum.
| Metabolic Reaction Equations | Metabolic Node Reaction Rate Equations |
|---|---|
| Glycolysis pathway (EMP): | (1) GLC: GLC(e) − r1 = 0 |
| r1: GLC + ATP → G6P + ADP | (2) G6P: r1 − r2 − r10 = 0 |
| r2: G6P → F6P | (3) F6P: r2 − r3 + r13 + r14 = 0 |
| r3: F6P + ATP → 2GA3P + ADP | (4) GA3P: 2r3 − r4 + r14 = 0 |
| r4: GA3P + NAD + PI + 2ADP → PYR + NADH + 2ATP | (5) PYR: r4 − r5 − r6 = 0 |
| Tricarboxylic acid cycle (TCA): | (6) AcCoA: r5 − r7 − 2r15 − r16 = 0 |
| r5: PYR + CoA + NAD → AcCoA + NADH + CO2 | (7) ICI: r7 − r8 = 0 |
| r6: PYR + ATP + CO2 → OAA + ADP + PI | (8) α-KG: r8 − r9 = 0 |
| r7: OAA + AcCoA → ICI + CoA | (9) OAA: r6 − r7 + r9 = 0 |
| r8: ICI + NADP → α − KG + NADPH + CO2 | (10) Ru5P: r10 − r11 − r12 = 0 |
| r9: α − KG + 2NAD + FAD + ADP + PI | (11) X5P: r11 − r13 − r14 = 0 |
| Pentose phosphate pathway (PP): | (12) R5P: r12 − r13 = 0 |
| r10: G6P + 2NADP → Ru5P + 2NADPH + CO2 | (13) E4P: r13 − r14 = 0 |
| r11: Ru5P → X5P | (14) CoA: -r5 + r7 + r15 + 2r16 = 0 |
| r12: Ru5P → R5P | (15) AcAcCoA: r15 − r16 = 0 |
| r13: X5P + R5P → F6P + E4P | (16) IPP: r16 − r17 − r18 − r19 − r20 = 0 |
| r14: X5P + E4P → F6P + GA3P | (17) DMAPP: r17 − r18 = 0 |
| Ganoderic acids R, S, T synthesis pathway (GAP): | (18) GPP: r18 − r19 = 0 |
| r15: 2AcCoA → AcAcCoA + CoA | (19) FPP: r19 − r20 − 2r21 = 0 |
| r16: AcAcCoA + AcCoA + 2NADPH + 2H+ + 3ATP + H2O | (20) SQ: r21 − r22 = 0 |
| r17: IPP → DMAPP | (21) OS: r22 − r23 = 0 |
| r18: DMAPP + IPP → GPP + PPI | (22) LAN: r23 − r24 − r25 − r26 = 0 |
| r19: GPP + IPP → FPP + PPI | (23) ERG: r24 − ERG(e) = 0 |
| r20: FPP + IPP → GGPP + PPI | (24) GaR: r26 − GaR(e) = 0 |
| r21: 2FPP + NADPH + H+ → SQ + NADP+ + 2PPI | GaS: r26 − GaS(e) = 0 |
| r22: SQ + O2 + NADPH + H+ → OS + NADP+ + H2O | GaT: r26 − GaT(e) = 0 |
| r23: OS → LAN | |
| r24: LAN → ERG | |
| r25: LAN → MY | |
| r26: LAN → GaR/GaS/GaT |
Figure 3Metabolic flux distribution of ganoderic acid R, synthesized by submerged fermentation-static culture under two methods of oleic acid addition. Left: Control (the 10th day of static culture); Middle: Filter-sterilized oleic acid (15th day of static culture); Right: High-temperature-sterilized oleic acid (10th day of static culture).
Figure 4Metabolic flow distribution of ganoderic acid S, synthesized by submerged fermentation-static culture under two methods of oleic acid addition. Left: Control (the 10th day of static culture); Middle: Filtration-sterilization oleic acid (20 days of static culture); Right: High-temperature-sterilization oleic acid (10 days of static culture).
Figure 5Metabolic flow distribution of ganoderic acid T, synthesized by submerged fermentation-static culture under two methods of oleic acid addition. Left: Control (the 20th day of static culture); Middle: Filtration-sterilization oleic acid (20 days of static culture); Right: High-temperature-sterilization oleic acid (10 days of static culture).
Statistics of metabolic pathway flow direction of ganoderic acids R, S and T, synthesized by submerged fermentation-static culture under two methods of oleic acid addition.
| Metabolic Pathway | Control | Filter-Sterilized Oleic Acid | High-Temperature-Sterilized Oleic Acid | ||
|---|---|---|---|---|---|
| Flow | Increasing Rate (%) | Flow | Increasing Rate (%) | ||
| Ganoderic acid R | |||||
| EMP | 362.17 | 370.75 | 2.37 | 379.93 | 4.91 |
| TCA | 279.42 | 329.46 | 17.91 | 383.00 | 37.07 |
| PP | 302.57 | 347.36 | 14.80 | 395.28 | 30.64 |
| Ganoderic acid R synthesis pathway (GaRP) | 423.70 | 614.77 | 45.10 | 819.22 | 93.35 |
| Ganoderic acid S | |||||
| EMP | 373.41 | 388.75 | 4.11 | 395.02 | 5.79 |
| TCA | 344.94 | 434.39 | 25.93 | 470.98 | 36.54 |
| PP | 361.22 | 441.27 | 22.16 | 474.03 | 31.23 |
| Ganoderic acid S synthesis pathway (GaSP) | 673.91 | 1015.16 | 50.64 | 1154.66 | 71.34 |
| Ganoderic acid T | |||||
| EMP | 373.76 | 384.03 | 2.75 | 390.82 | 4.57 |
| TCA | 346.98 | 406.87 | 17.26 | 446.47 | 28.67 |
| PP | 363.05 | 416.64 | 14.76 | 452.09 | 24.53 |
| Ganoderic acid T synthesis pathway (GaTP) | 681.70 | 910.28 | 33.53 | 1061.26 | 55.68 |